1. The University of Texas MD Anderson Cancer Center, Invectys and the Cell Therapy Manufacturing Center entered a strategic collaboration last week to develop a “reliable, compliant and scalable” process for human leukocyte antigen CAR-T cell therapy for solid tumors.
2. Houston-based University of Texas MD Anderson Cancer Center will establish the Andrew M. McDougall Brain Metastasis Clinic and Research Program after a $5 million gift from the McDougall family, The Journal Record reported June 14.
3. Boston-based Dana-Farber Cancer Institute signed a cooperation agreement with L’Institut Servier and Gustave Roussy in Villejuif, France, on June 7.
4. Eric Winer, MD, director of New Haven, Conn.-based Yale Cancer Center and physician-in-chief of Smilow Cancer Network, began a one-year term as president of the American Society of Clinical Oncology on June 7.
At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.
